Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statistical methods to disentangle genetic effects influencing infertility and early fetal viability with a genome-wide application. | PLoS Genet | 2025 | 41325449 | PubTator, text mining | PubMed |
| Emerging roles of natural killer cell ligands-HLA-E, HLA-F, HLA-G, MICA, and MICB-in in vitro fertilization outcomes. | Front Genet | 2025 | 41321564 | PubTator, text mining | PubMed |
| Genetic Variants Specific to Critical COVID-19: Insights From Genome-Wide Association Studies and Structural Analysis. | J Med Virol | 2025 | 41268733 | PubTator, text mining | PubMed |
| Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives. | Mol Cancer | 2025 | 41188940 | PubTator, text mining | PubMed |
| Genetic Variability in NKG2 Receptors and Their Ligands: Associations with SARS-CoV-2 Infection and COVID-19 Severity. | Genes (Basel) | 2025 | 41153412 | PubTator, text mining | PubMed |
| The HLA-B*57:01 Haplotype, Genetic Key Linking Innate Immunity and Longevity. | Aging Dis | 2025 | 41135092 | PubTator, text mining | PubMed |
| NKp30 and NKG2D contribute to natural killer cell-mediated recognition of HIV-infected cells. | iScience | 2025 | 41079618 | PubTator, text mining | PubMed |
| Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy. | Mol Ther Oncol | 2025 | 41050431 | PubTator, text mining | PubMed |
| Risk and Association of Specific HLA Alleles With Nintedanib-Induced Gastrointestinal Adverse Reactions: A Discovery Study in an Italian Population. | Clin Transl Sci | 2025 | 41017748 | PubTator, text mining | PubMed |
| Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening. | PLoS Comput Biol | 2025 | 40996951 | PubTator, text mining | PubMed |
| SH3BP5-driven metabolic-immune crosstalk in DLBCL: a prognostic biomarker and therapeutic target for reshaping immunosuppressive microenvironment. | J Transl Med | 2025 | 40993727 | PubTator, text mining | PubMed |
| Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia. | Leukemia | 2025 | 40954213 | PubTator, text mining | PubMed |
| The Role of MICA/B Molecules and the NKG2D Receptor in the Interaction Between NK-92 Cells and JEG-3 Cells. | Int J Mol Sci | 2025 | 40943323 | PubTator, text mining | PubMed |
| HLA Class Ib and MICA/MICB Expression in Human Tissues and Cell Types: Reshuffling Immune Players. | HLA | 2025 | 40928428 | PubTator, text mining | PubMed |
| Evaluating the causal effect of circulating proteome on the risk of Juvenile idiopathic arthritis: an omics pipeline study. | Pediatr Rheumatol Online J | 2025 | 40898345 | PubTator, text mining | PubMed |
| MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines. | Noncoding RNA | 2025 | 40863726 | PubTator, text mining | PubMed |
| Regulatory Effects of Endometriosis-Associated Genetic Variants: A Multi-Tissue eQTL Analysis. | Diseases | 2025 | 40863222 | PubTator, text mining | PubMed |
| Donor Variability and Seeding Density Shape NK-Cell Proliferation and Surface Receptor Expression: Insights from an Integrated Phenotypic and Genetic Analysis. | Cells | 2025 | 40862731 | PubTator, text mining | PubMed |
| Pinpointing novel targets for osteoarthritis: A comprehensive cross-omics integration analysis. | Medicine (Baltimore) | 2025 | 40859561 | PubTator, text mining | PubMed |
| Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. | J Exp Clin Cancer Res | 2025 | 40849493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=4